In Vitro Activities of Faropenem against Clarithromycin Resistance Helicobacter pylori Isolates
Miyuki Hasegawa, Takeshi Saika, Kaoru Matsuzaki, Intetsu KOBAYASHI, Toshio Fujioka, Masaru Nasu, Katsu Saionji, J Igari
Abstract
Open-access reader
Miyuki Hasegawa, Takeshi Saika, Kaoru Matsuzaki, Intetsu KOBAYASHI, Toshio Fujioka, Masaru Nasu, Katsu Saionji, J Igari
Abstract
Open-access reader
Agar dilution and semi-solid agar dilution were used to determine the MIC of faropenem (FRPM) against 24 H. pylori isolates. FRPM was active against clarithromycin resistance H. pylori isolates. And, the MICs obtained by both methods were in agreement. The results suggest that FRPM was not affected by pH and is a clinically useful oral antibiotic for the eradication therapy of H. pylori infections.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Agar dilution and semi-solid agar dilution were used to determine the MIC of faropenem (FRPM) against 24 H. pylori isolates. FRPM was active against clarithromycin resistance H. pylori isolates. And, the MICs obtained by both methods were in agreement. The results suggest that FRPM was not affected by pH and is a clinically useful oral antibiotic for the eradication therapy of H. pylori infections.
Key concepts: Clarithromycin, Helicobacter pylori, Microbiology, In vitro, Biology, Medicine, Internal medicine, Genetics